Indication · Neurology & Neurosurgery
Brain tumors
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
106
Cleared or approved since 2000
PMA and De Novo
11
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
80
450 device trials in all
Devices
1 devices via De Novo. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Leica FL400
Leica Microsystems (Schweiz) AG · De Novo · Diagnostic Neurosurgical Microscope Filter · newest 2019
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- CONVIVO EndomicroscopyRecruiting
Northwell HealthAcademic, hospital or other
NCT06087393 · 30 participants (planned) · Start Jan 8, 2024 · Primary completion Oct 1, 2028
Device: CONVIVO · For: Brain Tumor
Sites: Manhasset, New York
449 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on glioblastoma across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.